Can benign tumors shrink with chemotherapy?

In general, whether a benign tumor will shrink with chemotherapy depends on specific factors such as the tumor type, its sensitivity to chemotherapeutic agents, and the treatment goal. If there are any concerns regarding treatment, it is recommended to seek timely medical consultation. The detailed analysis is as follows:

If the benign tumor is sensitive to chemotherapy drugs and the treatment aim is to reduce tumor size to relieve compression symptoms, the tumor may shrink after chemotherapy. Although some benign tumors lack malignant proliferative characteristics, certain chemotherapeutic agents can inhibit their cell growth, slow down proliferation, or even induce partial cell apoptosis, thereby reducing tumor volume, alleviating pressure on surrounding tissues, and improving physical discomfort.

However, if the benign tumor is insensitive to chemotherapy drugs or the treatment goal is not tumor reduction, the tumor typically will not shrink following chemotherapy. Most benign tumors grow slowly and their cells show minimal response to chemotherapy, making it difficult for chemotherapy to significantly affect tumor size. In such cases, chemotherapy is generally not considered a primary treatment approach, and inappropriate use may lead to potential side effects.

After detecting a benign tumor, it is essential to first confirm the tumor type and assess the necessity of treatment, avoiding blind selection of chemotherapy. During chemotherapy, closely monitor bodily reactions; if severe side effects such as nausea, vomiting, or hair loss occur, promptly inform the doctor to adjust the treatment plan. After treatment, regularly follow up to monitor changes in tumor size. At the same time, maintain regular作息 (daily routines) and a balanced diet to enhance the body's tolerance. Never擅自 (unauthorized) alter the treatment plan in pursuit of tumor shrinkage.